ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 602613 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 602613; 2) Community: the network communities that were significantly associated with the response to NSC 602613; 3) Molecule: the relationships between components within communities and NSC 602613; 4) MDR: the compounds that were significantly associated with the NSC 602613.

NSC Compound Enrichment Correlation
NSC 742149 Bisarylpurine 0.0284045326811618 0.34998594
NSC 748541 1-Methylene-2-(4-methoxybenzyl)-3-(3-chlorophenyl)-1,2-dihydropyrazino[1,2-a]-benzimidazole 0.0284045326811618 0.50414749
NSC 750501 1,5-bis[4-(N-butylamidino)phenoxy]-3-tiapentane dihydrochloride 0.0284045326811618 0.10135752
NSC 75520 Thymidine, .alpha.,.alpha.,.alpha.-trifluoro- (8CI 9CI) 0.0284045326811618 0.43413741
NSC 757925 3,5-bis(4-hydroxy-3-methoxystyryl)-N-(4-fluorophenyl)-1H-pyrazole-1-carboxamide 0.0284045326811618 0.57009406
NSC 759630 LANATOSIDE C 0.0284045326811618 0.17139712
NSC 94945 Questiomycin A 0.0284045326811618 -0.0096975413
NSC 98572 .beta.-Resorcylaldehyde, 2-pyridylhydrazone 0.0284045326811618 0.31368413
NSC 105132 Deoxycamptothecin 0.0286383688883668 0.34294165
NSC 132791 Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo 0.0286383688883668 0.324423
Total:106  Current:65    [First] [Prev] [Next] [Last]